Understanding Retatrutide: A New Entrant in Weight-Loss Medications | Retatrutide News

Retatrutide is a new weight-loss drug developed by Eli Lilly, categorized as a GLP-1 agonist. The article discusses its potential impact on weight manag...
Weight Loss · October 12, 2026